MACULAR DEGENERATION ASSOCIATION ANNOUNCES O.D. EDUCATIONAL CRUISE PROGRAM

PRIMARY CARE FOR THE EYE:
Screening for, Managing & Treating
Macular Degeneration & Other
Eye Diseases
O.D. EDUCATIONAL CRUISE PROGRAM
January 22th – 29th, 2012
Eastern Caribbean Cruise
Sailing from Port Everglades in Ft. Lauderdale, FL

The Macular Degeneration Association (MDA) announces a special continuing education event for optometrists: MDA will host an Educational Cruise scheduled for January 22 – January 29, 2012. Program attendees will earn CE hours while traveling to exotic locations including the Bahamas, St. Thomas, and St. Maarten.

Departing from Port Everglades in Ft. Lauderdale, Florida, cruisers will set sail on a seven-night Eastern Caribbean adventure aboard Royal Caribbean’s Allure of the Seas. In collaboration with MDA, University at Sea will host the CE course program, offering participants the opportunity to earn up to 14 COPE credit hours. CE Participants will also enjoy complimentary social activities including a trade show, and both “Welcome Aboard” and “Bon Voyage” cocktail parties.

The CE Program will feature several eye professionals, including optometrist Diana Shechtman, O.D., F.A.O.O. CE educational sessions will also be given by MDA Scientific Co-Founder/Medical Director & Retina Specialist Michael Tolentino, M.D., renowned for developing revolutionary treatment strategies to slow the progression of macular degeneration.

CE course topics include Macular Degeneration: Risk Assessment, Treatments & Therapies; Differentiating Various Retinal Technologies; Genetics and Retinal Disease; and Eye Drops for Wet AMD.

MDA’s Educational Cruise Program will provide attendees with a unique opportunity to earn CE credit hours and interact with nationally known macular experts, and other eye care professionals.

For more information on the cruise, and to register, contact University at Sea at 800-422-0711. The cruise registration deadline is November 3, 2011.

The Macular Degeneration Association is a nonprofit health organization dedicated to educating and empowering age-related macular degeneration patients all across the world. Age-related macular degeneration (AMD) is an increasingly prevalent degenerative eye disease, affecting millions of aging seniors. The mission of MDA is to educate patients on the latest advances in treating AMD. However, our focus extends far beyond diagnosed patients. We are committed to the senior population at large, those most at risk of developing macular degeneration.

Our goal is to provide information about risk factors, genetic predisposition, and proper diagnosis, as well as preventative efforts and treatment options that will likely reduce the most adverse effect of AMD, blindness. MDA is passionate about funding and developing sophisticated patient education and advocacy programs designed to improve macular patients’ quality of life. This is accomplished through the Association’s patient education conferences and seminars held nationwide.

The Association honors its commitment to prioritizing patient education by aligning itself with experts in the macular field, investigating retina-related scientific breakthroughs, and disseminating new scientific advances to macular patients across the world. We strongly believe that providing support, education and empowerment to the millions of people living with age-related macular degeneration will improve patient quality of life, and energize the retina field to develop advances in treating AMD.

It is our hope that encouraging knowledge and awareness will ultimately lead to a cure.
For more information, please visit the MDA website at: www.maculardegenerationassociation.org or contact Lynne Henry at (941) 870-4399.

Macular Degeneration Association
Lynne Henry
PO BOX 20256
Sarasota, FL 34276
USA

This release was published on openPR.